187 related articles for article (PubMed ID: 25861950)
1. A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo.
Pan R; Xu W; Yuan F; Chu D; Ding Y; Chen B; Jafari M; Yuan Y; Chen P
Acta Biomater; 2015 Jul; 21():74-84. PubMed ID: 25861950
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of endosomolytic biocompatible peptides as carriers for siRNA delivery.
Xu W; Pan R; Zhao D; Chu D; Wu Y; Wang R; Chen B; Ding Y; Sadatmousavi P; Yuan Y; Chen P
Mol Pharm; 2015 Jan; 12(1):56-65. PubMed ID: 25378277
[TBL] [Abstract][Full Text] [Related]
3. Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing.
Tanaka K; Kanazawa T; Ogawa T; Takashima Y; Fukuda T; Okada H
Int J Pharm; 2010 Oct; 398(1-2):219-24. PubMed ID: 20674725
[TBL] [Abstract][Full Text] [Related]
4. Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide.
Chen B; Pan R; Askhatova D; Chen P
Int J Nanomedicine; 2015; 10():3303-14. PubMed ID: 25999710
[TBL] [Abstract][Full Text] [Related]
5. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
6. Highly branched HK peptides are effective carriers of siRNA.
Leng Q; Scaria P; Zhu J; Ambulos N; Campbell P; Mixson AJ
J Gene Med; 2005 Jul; 7(7):977-86. PubMed ID: 15772938
[TBL] [Abstract][Full Text] [Related]
7. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo.
Tai Z; Wang X; Tian J; Gao Y; Zhang L; Yao C; Wu X; Zhang W; Zhu Q; Gao S
Biomacromolecules; 2015 Apr; 16(4):1119-30. PubMed ID: 25686200
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.
Langlet-Bertin B; Leborgne C; Scherman D; Bechinger B; Mason AJ; Kichler A
Pharm Res; 2010 Jul; 27(7):1426-36. PubMed ID: 20393870
[TBL] [Abstract][Full Text] [Related]
12. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
[TBL] [Abstract][Full Text] [Related]
13. RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system.
Kim SW; Kim NY; Choi YB; Park SH; Yang JM; Shin S
J Control Release; 2010 May; 143(3):335-43. PubMed ID: 20079391
[TBL] [Abstract][Full Text] [Related]
14. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
[TBL] [Abstract][Full Text] [Related]
15. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
16. DEGylation Enhanced the Stability of Peptide-siRNA Complexes in Serum.
Pan R; Xu W; Jafari M; Chen B; Sheinin T; Chen P
J Nanosci Nanotechnol; 2015 Dec; 15(12):9982-90. PubMed ID: 26682443
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of ionizable peptide amphiphiles for siRNA delivery.
Neuberg P; Wagner A; Remy JS; Kichler A
Int J Pharm; 2019 Jul; 566():141-148. PubMed ID: 31125716
[TBL] [Abstract][Full Text] [Related]
19. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
[TBL] [Abstract][Full Text] [Related]
20. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
